CGM Cegedim SA

Cegedim: Growth continued in third quarter 2023

Cegedim: Growth continued in third quarter 2023

 
 



PRESS RELEASE

Quarterly financial information as of September 30, 2023

IFRS - Regulated information - Not audited

Cegedim: Growth continued in third quarter 2023

  • Q3 2023 revenues grew 11.3% to €148.3 million
  • All operating divisions contributed to growth
  • Over the first nine months of 2023 revenues reaches €449.3 million

Boulogne-Billancourt, France, October 26, 2023, after the market close

Revenue

 Third quarterChange Q3 2023 / 2022Nine monthsChange 9M 2023 / 2022
in millions of euros20232022ReportedLike for like20232022ReportedLike for like (1)(2)
Software & Services80.775.27.3%7.4%242.2220.89.7%9.5%
Flow22.921.56.6%6.6%71.166.76.6%6.8%
Data & Marketing24.122.85.7%5.7%79.072.88.6%7.9%
BPO19.013.046.2%46.2%51.838.435.0%35.0%
Corporate and others(3)1.60.8111.5%111.5%5.12.1143.1%143.1%
Cegedim148.3133.311.3%11.4%449.3400.812.1%11.9%

(1)   At constant scope and exchange rates

(2)   The positive currency impact of 0.2% was mainly due to the pound sterling. The positive scope effect of 0.4% was attributable to the first-time consolidation in Cegedim’s accounts of new acquisitions Mesdocteurs, Laponi, and Clinityx.

(3)   Since the beginning of 2023, the Corporate division has included specific hosting activities previously housed in the Software and Services division





posted third-quarter revenue growth of 11.3% on a reported basis and 11.4% like for like(1) compared with third quarter 2022. This confirms the first-half trend showing revenues on the right track.

Through end-September, Cegedim posted cumulative revenue growth of 12.1% on a reported basis and 11.9% like for like(1) compared with the first nine months of 2022.

Analysis of business trends by division

  • Software & Services
Software & ServicesThird quarterChange Q3 2023 / 2022Nine monthsChange 9M 2023 / 2022
in millions of euros20232022ReportedLike for like20232022ReportedLike for like
Cegedim Santé18.618.50.5%0.5%58.450.316.1%14.0%
Insurance, HR, Pharmacies and other services48.744.78.9%8.9%144.0134.57.1%6.9%
International businesses13.512.011.8%12.2%39.836.010.5%12.4%
Software & Services80.775.27.3%7.4%242.2220.89.7%9.5%

Cegedim Santé’s dynamic growth so far this year slowed down in the third quarter owing mainly to tougher comparisons related to Ségur public health investments. Performance over nine months remains very robust, with like-for-like growth of 14%.

The division’s other businesses in France sustained growth of around 7%, buoyed by the HR and pharmacy units (the first wave of “Ségur de la Santé” for the pharmacy segment).

International businesses built on strong first-half trends, posting 12% growth in the third quarter. Bright spots included the doctor segment in Spain and the doctor, pharmacist, and insurance segments in the UK.

  • Flow
FLOWThird quarterChange Q3 2023 / 2022Nine monthsChange 9M 2023 / 2022
in millions of euros20232022ReportedLike for like20232022ReportedLike for like
SY / E Business14.012.98.9%8.9%43.340.17.9%8.1%
Third-party payer8.98.63.2%3.2%27.926.64.8%4.8%
Flow22.921.56.6%6.6%71.166.76.6%6.8%

The electronic invoicing and digital data flow business grew nearly 9% in the third quarter. Both French and international activities contributed to growth.

Flow businesses related to health spending in France (Third-party payer) posted 3.2% year-on-year growth in the third quarter and 4.8% over nine months. Invoicing related to the Allianz third-party payer contract now falls under BPO services (switch was made on April 1st).

  • Data & Marketing
Data & MarketingThird quarterChange Q3 2023 / 2022Nine monthsChange 9M 2023 / 2022
in millions of euros20232022ReportedLike for like20232022ReportedLike for like
Data14.614.31.9%1.9%43.440.47.6%6.4%
Marketing9.58.512.2%12.2%35.632.49.8%9.8%
Data & Marketing24.122.85.7%5.7%79.072.88.6%7.9%

Growth in Data business was modest, at 2% year on year, bringing growth over nine months to 7.6%.

On the Marketing side, advertising in pharmacies was dynamic in the third quarter, up 12.2%, resulting in 9M growth of nearly 10%.

  • BPO
BPOThird quarterChange Q3 2023 / 2022Nine monthsChange 9M 2023 / 2022
in millions of euros20232022ReportedLike for like20232022ReportedLike for like
Insurance BPO13.88.170.4%70.4%35.923.751.5%51.5%
HR BPO5.24.96.3%6.3%15.914.78.4%8.4%
BPO19.013.046.2%46.2%51.838.435.0%35.0%

Insurance BPO posted growth of 70% in the third quarter and 51.5% over the first nine months, driven by the April 1 start of the Allianz contract and overflow business.

Development in BPO for HR departments continues, with cumulative growth of 8.4% since the start of the year.

Highlights

To the best of the company's knowledge, there have been no national or international events or changes during the third quarter of 2023 that would be likely to have a material impact on the Group's financial position.

Significant transactions and events post September 30, 2023

Apart from the items cited below, to the best of the company’s knowledge, there were no events or changes post September 30, 2023, that would materially alter the Group’s financial situation.

Outlook

Based on nine-month 2023 revenues up 11.9% like for like, and despite the public health, economic, geopolitical, and monetary uncertainty facing the world, the Group is confident it can grow full-year revenues by 11% to 12% and improve its recurring operating income.

WEBCAST ON OCTOBER 26, 2023, AT 6:15 PM (PARIS TIME)
The webcast is available at: /webcast
 
The presentation of 9M 2023 revenues is available:



  • − On the website:
  • − And on the Cegedim IR smartphone app, available at
 
 

We will release our 2024 financial calendar in the fourth quarter of 2023 at the following address: /finance/agenda/Pages/default.aspx

Disclaimer

This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim’s authorized distributor on October 26, 2023, no earlier than 5:45 pm Paris time.

The figures cited in this press release include guidance on Cegedim's future financial performance targets. This forward-looking information is based on the opinions and assumptions of the Group’s senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 7, “Risk management”, section 7.2, “Risk factors and insurance”, and Chapter 3, “Overview of the financial year”, section 3.6, “Outlook”, of the 2022 Universal Registration Document filled with the AMF on April 12, 2023, under number D.23-0266.



 
 



About Cegedim:



Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 6,000 people in more than 10 countries and generated revenue of €555 million in 2022.

Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit:

And follow Cegedim on Twitter : , and .


Aude Balleydier

Cegedim

Media Relations

and Communications Manager

Tel.: +33 (0)1 49 09 68 81



Jérôme Moreau

Cegedim

Director of Management Control

Head of Financial Communication

Tel.: +33 (0)7 85 63 61 99



Céline Pardo

.becoming

Media Relations



 



Tel.: +33 (0)6 52 08 13 66

 





Annexes

Breakdown of revenue by quarter and division

  • Year 2023
in millions of euros Q1Q2Q3Q4Total
Software & Services 80.481.180.7 242.2
Flow 24.823.422.9 71.1
Data & Marketing 24.630.324.1 79.0
BPO 14.418.419.0 51.8
Corporate and others 1.61.91.6 5.1
Group revenue 145.9155.1148.3 449.3
  • Year 2022
in millions of euros Q1Q2Q3Q4Total
Software & Services 71.274.475.281.1302.0
Flow 22.622.621.523.990.6
Data & Marketing 22.527.622.834.1106.9
BPO 12.313.113.014.653.0
Corporate and others 0.70.70.80.72.8
Group revenue 129.2138.3133.3154.4555.2

Breakdown of revenue by geographic zone, currency, and division at September 30, 2023

as a % of consolidatedrevenues



 
 Geographic zone Currency
 FranceEMEA

ex. France
Americas EuroGBPOthers
Software & Services 83.6%16.3%0.1% 86.6%11.9%1.6%
Flow 91.6%8.4%0.0% 94.4%5.6%0.0%
Data & Marketing 97.4%2.6%0.0% 97.7%0.0%2.3%
BPO 100.0%0.0%0.0% 100.0%0.0%0.0%
Corporate and others 99.9%0.1%0.0% 100.0%0.0%0.0%
Cegedim 89.4%10.6%0.1% 91.5%7.3%1.2%

Attachment



EN
26/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cegedim SA

 PRESS RELEASE

Hospitalis lance Hospi-Secu à destination des fournisseurs de produits...

Hospitalis lance Hospi-Secu à destination des fournisseurs de produits de santé, pour sécuriser et tracer les flux transactionnels entre établissements de santé et fabricants  Après le succès d'Hospi-Secu lancé en 2024 pour les établissements prenant en charge des patients (hôpitaux, EHPAD…), , filiale du Groupe Cegedim et spécialiste des solutions digitales pour les fonctions finance, achats, ventes et RH, annonce aujourd'hui le lancement du module Hospi-Secu à destination des fournisseurs de produits de santé, une solution de sécurisation et de traçabilité des échanges logistiques spécifi...

 PRESS RELEASE

Claude Bernard annonce un partenariat stratégique avec RenAdaptor, exp...

Claude Bernard annonce un partenariat stratégique avec RenAdaptor, expert en adaptation posologique pour l’insuffisance rénale Ensemble, ils unissent leurs expertises pour sécuriser et simplifier la prescription chez les patients atteints d’une insuffisance rénale Boulogne-Billancourt, France, le 15 mai 2025 – Face à une problématique de santé publique majeure, , acteur de référence dans la gestion des bases de données des médicaments et des produits de santé, s’associe à RenAdaptor, expert en adaptation posologique pour l’insuffisance rénale, pour proposer ensemble une solution innovante ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 05/12/2025

Pharma: Donald Trump wants to cut the price of prescription drugs|ams OSRAM launches a consent request to amend the convertible notes|MPS published strong Q1 2025 results /the offer for Bacred is proceeding according to schedule|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 12/05/2025

Pharma : Donald Trump veut réduire le prix des médicaments sur ordonnance|ams OSRAM lance une demande de consentement visant les obligations convertibles|MPS a publié de solides résultats T1 2025 et poursuit son offre sur Mediobanca|

 PRESS RELEASE

Cegedim : projet de transfert de ses actions sur Euronext Growth Paris...

Cegedim : projet de transfert de ses actions sur Euronext Growth Paris.  COMMUNIQUE DE PRESSE Information boursière Boulogne-Billancourt, le 9 mai 2025 - , Groupe innovant de technologies et de services, annonce son projet de transfert de ses actions sur Euronext Growth® Paris. A l’occasion de sa prochaine Assemblée Générale, le 13 juin 2025, il sera demandé aux actionnaires d’approuver le projet de radiation des titres de CEGEDIM S.A. des négociations sur le marché règlementé Euronext Paris et leur admission concomitante sur Euronext Growth, dans un délai de 12 mois à compter de l’Ass...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch